Pharmaceutical Composition for Inhibiting Altering Gene Expression and for Inducing Differentiation in Non-Malignant Cells
United Kingdom
04015994.9
Filed on 1992-10-13
04015994.9
Filed on 1992-10-13
Pharmaceutical Composition for Inhibiting Altering Gene Expression and for Inducing Differentiation in Non-Malignant Cells
France
04015994.9
Filed on 1992-10-13
04015994.9
Filed on 1992-10-13
Pharmaceutical Composition for Inhibiting Altering Gene Expression and for Inducing Differentiation in Non-Malignant Cells
Germany
04015994.9
Filed on 1992-10-13
04015994.9
Filed on 1992-10-13
Immunogenic Peptides And Peptide Derivatives For Prostate And Breast Cancer Treatment
US Patent 8,043,623
Filed on 2009-04-27
Filed on 2009-04-27
RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN
European Patent
09005114.5
Filed on 2009-04-07
09005114.5
Filed on 2009-04-07
Regulation Of Skin Characteristics By Dickkopf 1 (DKK1)
US Patent 8,198,244
Filed on 2009-06-05
Filed on 2009-06-05
Single Chain Antibodies that Bind to Chondroitin Sulfate Proteoglycans
US Application 12/418,956
Filed on 2009-04-06
Filed on 2009-04-06
Dual Specific Immunotoxin for Brain Tumor Therapy
US Application 12/418,975
Filed on 2009-04-06
Filed on 2009-04-06
A Method For Identifying Patients At Risk For Developing Her-2+ Breast Cancer Brain Metastases, Based On Molecular Characteristics Of The Formalin Fixed, Paraffin Embedded (FFPE) Primary Tumor
Patent Cooperation Treaty
PCT/US09/003330
Filed on 2009-06-01
PCT/US09/003330
Filed on 2009-06-01
A Gene Expression-based Survival Predictor For Diffuse Large B Cell Lymphoma Treated With Chemotherapy Plus Rituximab
Patent Cooperation Treaty
PCT/US2009/046421
Filed on 2009-06-05
PCT/US2009/046421
Filed on 2009-06-05